Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06789952 · ClinicalTrials.gov registry record · NA
Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT06789952 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 41 participants.
The verdict
NCT06789952, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Olfactory dysfunction (OD) is a defining symptom of COVID-19 infection. As the number of total, confirmed novel coronavirus SARS-CoV-2 (COVID-19) cases exceeds 45 million in the United States, it is estimated that up to 85% of infected patients will experience at least some olfactory dysfunction. Therefore, we propose a Pilot single-site clinical trial to explore the efficacy of MBSR for Covid-19-related smell distortion (parosmia)
Interventions
- BEHAVIORAL Lifestyle Intervention
- BEHAVIORAL Mindfulness-Based Stress Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06789952
The ClinicalTrials.gov registry entry for NCT06789952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lifestyle Intervention is the first listed.
NCT06789952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06789952 about?
NCT06789952 is a clinical study titled "Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia". Olfactory dysfunction (OD) is a defining symptom of COVID-19 infection. As the number of total, confirmed novel coronavirus SARS-CoV-2 (COVID-19) cases exceeds 45 million in the United States, it is estimated that up to 85% of infected patients will experience at least some olfactory dysfunction. T...
What is the current status of trial NCT06789952?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2023-09-06. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT06789952?
The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL), Mindfulness-Based Stress Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06789952?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.